Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer
暂无分享,去创建一个
E. Artamonova | K. Grechukhina | O. Sekhina | L. Zhukova | K. Vorontsova | I. Ganshina | I. Kolyadina
暂无分享,去创建一个
E. Artamonova | K. Grechukhina | O. Sekhina | L. Zhukova | K. Vorontsova | I. Ganshina | I. Kolyadina